Shares of Cambridge Cognition (LON:COG) traded up GBX 8.50 ($0.12) during mid-day trading on Wednesday, hitting GBX 129.50 ($1.76). 70,053 shares of the stock were exchanged, compared to its average volume of 8,362. Cambridge Cognition has a twelve month low of GBX 68.20 ($0.92) and a twelve month high of GBX 169 ($2.29).
About Cambridge Cognition
Cambridge Cognition Holdings plc and its subsidiaries develop and commercialize computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company’s segments include Pharmaceutical Clinical Trials, Academic Research and Healthcare Technology. The Pharmaceutical Clinical Trials segment includes products and services for use in regulated pharmaceutical clinical trials.
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.